Pacira | PCRX - Market Capitalization

Stock Price
22.02
Daily Change
0.08 0.36%
Monthly
-5.00%
Yearly
-9.31%
Q1 Forecast
22.56

Pacira reported $1.02B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Cara Therapeutics USD 28M 11M Dec/2024
Coherus Biosciences USD 94M 65M Mar/2025
Heron Therapeutics USD 133M 105M Mar/2026
J&J USD 500.24B 67.44B Dec/2025
Novo Nordisk A/S DKK 1.45T 86.62B Dec/2025
Pacira USD 1.06B 94M Dec/2025
Perrigo USD 1.92B 1.04B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Supernus Pharmaceuticals USD 2.85B 151M Dec/2025
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
Xeris Pharmaceuticals USD 1.32B 562M Sep/2025
Zoetis USD 55.45B 9.4B Dec/2025